We found that the top three most frequent OPA3 gene alterations were in cervical cancer tumors, BRCA, and ovarian cancer (Figure 2B), which also indicates that OPA3 is more frequently mutated in female cancers. The gene discussed is OPA3; the disease is ovarian carcinoma.